Anavex Life Sciences Corp (AVXL)

[bas2020]

To reiterate Xena's response... the data, especially the monotherapy data, indicated a potential curative effect at 31 wks, but is inconclusive only because of the small 'n'. As expressed in Anavex's PR...

"The study also offered encouraging evidence confirming the previously reported positive trends in some cognitive and biologic measures persisted over a period of approximately 31 weeks.

However, the company clarified that this analysis was based on a relatively small number of subjects receiving a variety of doses. Therefore, the company said that that these findings might not reflect the full potential of ANAVEX 2-73 in treating Alzheimer's disease."

AF and the shorting cabal are responsible for the rapid share price decline. They had a premeditated plan to attack, regardless of what the data showed.